-
Synthetic CT Generation via Variant Invertible Network for All-digital Brain PET Attenuation Correction
Authors:
Yu Guan,
Bohui Shen,
Xinchong Shi,
Xiangsong Zhang,
Bingxuan Li,
Qiegen Liu
Abstract:
Attenuation correction (AC) is essential for the generation of artifact-free and quantitatively accurate positron emission tomography (PET) images. However, AC of PET faces challenges including inter-scan motion and erroneous transformation of structural voxel-intensities to PET attenuation-correction factors. Nowadays, the problem of AC for quantitative PET have been solved to a large extent afte…
▽ More
Attenuation correction (AC) is essential for the generation of artifact-free and quantitatively accurate positron emission tomography (PET) images. However, AC of PET faces challenges including inter-scan motion and erroneous transformation of structural voxel-intensities to PET attenuation-correction factors. Nowadays, the problem of AC for quantitative PET have been solved to a large extent after the commercial availability of devices combining PET with computed tomography (CT). Meanwhile, considering the feasibility of a deep learning approach for PET AC without anatomical imaging, this paper develops a PET AC method, which uses deep learning to generate continuously valued CT images from non-attenuation corrected PET images for AC on brain PET imaging. Specifically, an invertible network combined with the variable augmentation strategy that can achieve the bidirectional inference processes is proposed for synthetic CT generation (IVNAC). To evaluate the performance of the proposed algorithm, we conducted a comprehensive study on a total of 1440 data from 37 clinical patients using comparative algorithms (such as Cycle-GAN and Pix2pix). Perceptual analysis and quantitative evaluations illustrate that the invertible network for PET AC outperforms other existing AC models, which demonstrates the potential of the proposed method and the feasibility of achieving brain PET AC without CT.
△ Less
Submitted 3 October, 2023;
originally announced October 2023.
-
Cooperation of myosin II in muscle contraction through nonlinear elasticity
Authors:
Beibei Shen,
Yunxin Zhang
Abstract:
Myosin II plays a pivotal role in muscle contraction by generating force through the cooperative action of multiple motors on actin filaments. In this study, we integrate the nonlinear elasticity of the neck linker in individual myosin II and comprehensively investigate the evolution of cooperativity and dynamics at {\it microstate} and {\it mesostate} levels using a combined model of single and m…
▽ More
Myosin II plays a pivotal role in muscle contraction by generating force through the cooperative action of multiple motors on actin filaments. In this study, we integrate the nonlinear elasticity of the neck linker in individual myosin II and comprehensively investigate the evolution of cooperativity and dynamics at {\it microstate} and {\it mesostate} levels using a combined model of single and multiple motors. We find that a substantial proportion of actin-bound motors reside in the {\it mid-} and {\it post-power stroke} states, and our nonlinear model reveals their increased capacity for load sharing. Additionally, we systematically explore the impact of mechanical load and ATP concentration on myosin II motors. Notably, we observe that the average net distance of actin undergoes a transition from a weak load-sensitive regime at low ATP concentrations to a load-sensitive regime at higher ATP concentrations. Furthermore, increasing the load or raising the ATP concentration to saturation can enhance the efficiency and output power of myosin filament. Moreover, the efficiency of the myosin filament increases with the power stroke strength, reaching a maximum at a specific range, and subsequently declining beyond that threshold. Finally, we explore the mean run time/length and mean existence probability of myosin filament, shedding light on its overall behavior.
△ Less
Submitted 19 June, 2023;
originally announced June 2023.
-
Balancing Exploration and Exploitation: Disentangled $β$-CVAE in De Novo Drug Design
Authors:
Guang Jun Nicholas Ang,
De Tao Irwin Chin,
Bingquan Shen
Abstract:
Deep generative models have recently emerged as a promising de novo drug design method. In this respect, deep generative conditional variational autoencoder (CVAE) models are a powerful approach for generating novel molecules with desired drug-like properties. However, molecular graph-based models with disentanglement and multivariate explicit latent conditioning have not been fully elucidated. To…
▽ More
Deep generative models have recently emerged as a promising de novo drug design method. In this respect, deep generative conditional variational autoencoder (CVAE) models are a powerful approach for generating novel molecules with desired drug-like properties. However, molecular graph-based models with disentanglement and multivariate explicit latent conditioning have not been fully elucidated. To address this, we proposed a molecular-graph $β$-CVAE model for de novo drug design. Here, we empirically tuned the value of disentanglement and assessed its ability to generate molecules with optimised univariate- or-multivariate properties. In particular, we optimised the octanol-water partition coefficient (ClogP), molar refractivity (CMR), quantitative estimate of drug-likeness (QED), and synthetic accessibility score (SAS). Results suggest that a lower $β$ value increases the uniqueness of generated molecules (exploration). Univariate optimisation results showed our model generated molecular property averages of ClogP = 41.07% $\pm$ 0.01% and CMR 66.76% $\pm$ 0.01% by the Ghose filter. Multivariate property optimisation results showed that our model generated an average of 30.07% $\pm$ 0.01% molecules for both desired properties. Furthermore, our model improved the QED and SAS (exploitation) of molecules generated. Together, these results suggest that the $β$-CVAE could balance exploration and exploitation through disentanglement and is a promising model for de novo drug design, thus providing a basis for future studies.
△ Less
Submitted 17 August, 2023; v1 submitted 2 June, 2023;
originally announced June 2023.
-
Predicting COVID-19 Pneumonia Severity on Chest X-ray with Deep Learning
Authors:
Joseph Paul Cohen,
Lan Dao,
Paul Morrison,
Karsten Roth,
Yoshua Bengio,
Beiyi Shen,
Almas Abbasi,
Mahsa Hoshmand-Kochi,
Marzyeh Ghassemi,
Haifang Li,
Tim Q Duong
Abstract:
Purpose: The need to streamline patient management for COVID-19 has become more pressing than ever. Chest X-rays provide a non-invasive (potentially bedside) tool to monitor the progression of the disease. In this study, we present a severity score prediction model for COVID-19 pneumonia for frontal chest X-ray images. Such a tool can gauge severity of COVID-19 lung infections (and pneumonia in ge…
▽ More
Purpose: The need to streamline patient management for COVID-19 has become more pressing than ever. Chest X-rays provide a non-invasive (potentially bedside) tool to monitor the progression of the disease. In this study, we present a severity score prediction model for COVID-19 pneumonia for frontal chest X-ray images. Such a tool can gauge severity of COVID-19 lung infections (and pneumonia in general) that can be used for escalation or de-escalation of care as well as monitoring treatment efficacy, especially in the ICU.
Methods: Images from a public COVID-19 database were scored retrospectively by three blinded experts in terms of the extent of lung involvement as well as the degree of opacity. A neural network model that was pre-trained on large (non-COVID-19) chest X-ray datasets is used to construct features for COVID-19 images which are predictive for our task.
Results: This study finds that training a regression model on a subset of the outputs from an this pre-trained chest X-ray model predicts our geographic extent score (range 0-8) with 1.14 mean absolute error (MAE) and our lung opacity score (range 0-6) with 0.78 MAE.
Conclusions: These results indicate that our model's ability to gauge severity of COVID-19 lung infections could be used for escalation or de-escalation of care as well as monitoring treatment efficacy, especially in the intensive care unit (ICU). A proper clinical trial is needed to evaluate efficacy. To enable this we make our code, labels, and data available online at https://github.com/mlmed/torchxrayvision/tree/master/scripts/covid-severity and https://github.com/ieee8023/covid-chestxray-dataset
△ Less
Submitted 30 June, 2020; v1 submitted 24 May, 2020;
originally announced May 2020.
